title: Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1.
abstract: Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant neuromuscular disorder that is not due to a classical mutation within a protein-coding gene. Instead, almost all FSHD patients carry deletions of an integral number of tandem 3.3-kilobase repeat units, termed D4Z4, located on chromosome 4q35 (ref. 3). D4Z4 contains a transcriptional silencer whose deletion leads to inappropriate overexpression in FSHD skeletal muscle of 4q35 genes located upstream of D4Z4 (ref. 4). To identify the gene responsible for FSHD pathogenesis, we generated transgenic mice selectively overexpressing in skeletal muscle the 4q35 genes FRG1, FRG2 or ANT1. We find that FRG1 transgenic mice develop a muscular dystrophy with features characteristic of the human disease; by contrast, FRG2 and ANT1 transgenic mice seem normal. FRG1 is a nuclear protein and several lines of evidence suggest it is involved in pre-messenger RNA splicing. We find that in muscle of FRG1 transgenic mice and FSHD patients, specific pre-mRNAs undergo aberrant alternative splicing. Collectively, our results suggest that FSHD results from inappropriate overexpression of FRG1 in skeletal muscle, which leads to abnormal alternative splicing of specific pre-mRNAs.
authors.affiliation: Howard Hughes Medical Institute, Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.
authors.forename: Davide
authors.initials: D
authors.lastname: Gabellini
authors.forename: Giuseppe
authors.initials: G
authors.lastname: D'Antona
authors.forename: Maurizio
authors.initials: M
authors.lastname: Moggio
authors.forename: Alessandro
authors.initials: A
authors.lastname: Prelle
authors.forename: Chiara
authors.initials: C
authors.lastname: Zecca
authors.forename: Raffaella
authors.initials: R
authors.lastname: Adami
authors.forename: Barbara
authors.initials: B
authors.lastname: Angeletti
authors.forename: Patrizia
authors.initials: P
authors.lastname: Ciscato
authors.forename: Maria Antonietta
authors.initials: MA
authors.lastname: Pellegrino
authors.forename: Roberto
authors.initials: R
authors.lastname: Bottinelli
authors.forename: Michael R
authors.initials: MR
authors.lastname: Green
authors.forename: Rossella
authors.initials: R
authors.lastname: Tupler
mesh_terms: D017398:Alternative Splicing / Q000235:genetics; D000818:Animals; D002460:Cell Line; D005260:Female; D006801:Humans; D007738:Kyphosis / Q000150:complications / Q000235:genetics / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D008840:Microfilament Proteins; D018482:Muscle, Skeletal / Q000473:pathology; D020391:Muscular Dystrophy, Facioscapulohumeral / Q000150:complications / Q000235:genetics* / Q000473:pathology* / Q000503:physiopathology; D009929:Organ Size; D005082:Physical Exertion / Q000502:physiology; D011506:Proteins / Q000235:genetics* / Q000378:metabolism*; D016601:RNA-Binding Proteins; D019076:Transgenes / Q000235:genetics*; D015431:Weight Loss
chemical_list: C484440:Frg1 protein, mouse; D008840:Microfilament Proteins; D011506:Proteins; D016601:RNA-Binding Proteins